Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley stage 1 hidradenitis suppurativa: prospective short-term trial and 1-year follow-up in 28 consecutive patients - Concepedia

Concepedia

Publication | Open Access

Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley stage 1 hidradenitis suppurativa: prospective short-term trial and 1-year follow-up in 28 consecutive patients

DOI Full Paper Access

29

Citations

29

References

2020

Year

M. Delage, Jean-Philippe Jaı̈s, Thi Lam, Hélène Guet‐Revillet, Marie‐Noëlle Ungeheuer, Paul‐Henri Consigny, Aude Nassif, Olivier Join‐Lambert

Journal of the American Academy of Dermatology

Consecutive PatientsRifampin-moxifloxacin-metronidazole Combination TherapyClinical DermatologyDermatologyMedicineHidradenitis Suppurativa

References

	Year	Citations

Page 1